Gainers
- Cyclerion Therapeutics CYCN stock moved upwards by 31.9% to $3.35 during Friday's pre-market session. The company's market cap stands at $9.0 million.
- LakeShore Biopharma LSB stock moved upwards by 21.42% to $2.89. The market value of their outstanding shares is at $55.1 million.
- OS Therapies OSTX shares rose 12.3% to $2.19. The company's market cap stands at $46.5 million.
- AquaBounty Techs AQB stock rose 11.18% to $0.77. The market value of their outstanding shares is at $2.9 million.
- Mainz Biomed MYNZ shares moved upwards by 9.52% to $5.85. The company's market cap stands at $12.9 million.
- BioSig Technologies BSGM stock increased by 9.32% to $0.9. The market value of their outstanding shares is at $15.5 million.
Losers
- NewGenIvf Group NIVF shares fell 32.9% to $0.17 during Friday's pre-market session. The market value of their outstanding shares is at $2.3 million.
- Kazia Therapeutics KZIA stock fell 11.58% to $1.68. The company's market cap stands at $9.3 million.
- TruBridge TBRG shares decreased by 10.17% to $22.1. The company's market cap stands at $329.8 million.
- Cytek Biosciences CTKB shares declined by 9.72% to $5.11. The company's market cap stands at $658.2 million.
- Scienture Holdings SCNX stock fell 9.24% to $3.54. The market value of their outstanding shares is at $30.4 million.
- Concord Medical Services CCM shares fell 8.76% to $5.0. The company's market cap stands at $217.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BSGMBioSig Technologies Inc
$1.0223.9%
CCMConcord Medical Services Holdings Ltd
$5.00-8.76%
CTKBCytek Biosciences Inc
$5.14-9.10%
CYCNCyclerion Therapeutics Inc
$3.8652.0%
KZIAKazia Therapeutics Ltd
$1.56-17.9%
LSBLakeShore Biopharma Co Ltd
$2.8921.4%
MYNZMainz Biomed NV
$6.1314.8%
NIVFNewGenIvf Group Ltd
$0.1515-41.5%
OSTXOS Therapies Inc
$1.82-6.67%
SCNXScienture Holdings Inc
$3.87-0.77%
TBRGTruBridge Inc
$24.861.06%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in